Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (75 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > MD&A For your viewing pleasure !
View:
Comment by awn4688 on Sep 01, 2021 5:24am
This post has been removed in accordance with Community Policy
Comment by cashascars on Sep 01, 2021 8:53am
Is it just early in the morning with no coffee or was this the first time they mentioned patients 5&6 from phase 1 with one treatment were cancer free at 24 months. I thought the last we heard it was 18 months. Either way its so unbelievably that 1433 is works so well that 1 treatment can have such impact on patients that struggled with their cancer so much that they were at the end of any ...more  
Comment by enriquesuave on Sep 01, 2021 9:02am
WOW!  Just noticed that, PH1 patients 5 & 6 cancer free at up to 24 months after only one single treatment.  Let's hope we see a majority of those PH2 optimized treated patients do as well.  
Comment by Eoganacht on Sep 01, 2021 12:20pm
It's really remarkable that 2 of the first 3 patients that received the full dose were still cancer-free after 2 years. How is this not a cure? Even saying '67% of the first 3 were cured' may mislead one to underestimate the efficacy of the treatment as the patient who was not cured had pre-existing and non-Study related metastatic cancer and could not have been cured in the ...more  
Comment by Oilminerdeluxe on Sep 01, 2021 12:42pm
In other words, we have until next newsletter update to load up...
Comment by Eoganacht on Sep 01, 2021 12:47pm
I'm done! Yesterday I bought my final 20,000 shares.
Comment by Oilminerdeluxe on Sep 01, 2021 1:00pm
I am jealous. Man, if those six pending could show at least four healthy...
Comment by CAinPlap on Sep 01, 2021 1:13pm
It would be nice if we would hear some momentum behind patient enrollment and treatment. Is one patient per site per month asking too much? What is the bottleneck? WIlling and eligible patients?
Comment by 99942Apophis on Sep 01, 2021 2:19pm
CAinPlap wrote It would be nice if we would hear some momentum behind patient enrollment and treatment. Is one patient per site per month asking too much? What is the bottleneck? WIlling and eligible patients? My guess still falls on worker burn-out at many hospitals because of the virus, too bad Theralase's treatment wasn't readily available then there wouldn't be a worry about ...more  
Comment by socksnblonds642 on Sep 01, 2021 9:36am
Thank you for pointing that out. This is great data and the more we read it the better it gets. 
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 72 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250